Verition Fund Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-13,200
Closed -$593K 3389
2024
Q4
$593K Sell
13,200
-28,700
-68% -$1.61M ﹤0.01% 2372
2024
Q3
$2.63M Buy
41,900
+27,000
+181% +$1.58M 0.01% 1252
2024
Q2
$880K Buy
14,900
+1,100
+8% +$68.8K ﹤0.01% 1747
2024
Q1
$1.1M Buy
13,800
+10,300
+294% +$787K 0.01% 1560
2023
Q4
$276K Buy
+3,500
New +$249K ﹤0.01% 1845
2022
Q4
Sell
-10,800
Closed -$1.03M 2260
2022
Q3
$1.03M Buy
+10,800
New +$1.07M 0.01% 1373
2022
Q2
Sell
-36,300
Closed -$3.67M 2484
2022
Q1
$3.67M Buy
36,300
+20,400
+128% +$2.14M 0.04% 557
2021
Q4
$1.64M Buy
+15,900
New +$1.47M 0.01% 1003

Other funds holding CVS

Verition Fund Management's CVS Position: Q1 2026 in Review

Verition Fund Management reduced its CVS Health (CVS) stake by 7.6% in Q1 2026, selling an estimated $511K and leaving 80,760 shares worth $5.8M. The position accounts for 0.04% of the portfolio, ranked #519.

Verition Fund Management first reported a position in CVS in Q3 2013 and has held it in 41 quarters since. The position peaked at $22.7M in Q3 2023. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Verition Fund Management held 80,760 shares of CVS Health worth $5.8M as of Q1 2026.
  • Verition Fund Management sold 6,636 CVS Health shares in Q1 2026, an estimated $511K.
  • CVS Health made up 0.04% of Verition Fund Management's portfolio in Q1 2026, its #519 holding.
  • Verition Fund Management first reported a position in CVS Health in Q3 2013 and has held it in 41 quarters since.
  • Verition Fund Management's CVS Health position peaked at $22.7M in Q3 2023.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.